VANGUARD GROUP INC - APPLIED GENETIC TECHNOL CORP ownership

APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 51 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of APPLIED GENETIC TECHNOL CORP
ValueSharesWeighting
Q3 2022$401,000
-73.7%
1,477,636
-25.4%
0.00%
Q2 2022$1,526,000
-28.0%
1,981,5650.0%0.00%
Q1 2022$2,120,000
-35.6%
1,981,565
+14.4%
0.00%
Q4 2021$3,293,000
-37.0%
1,732,746
-0.2%
0.00%
Q3 2021$5,223,000
-23.0%
1,735,3720.0%0.00%
Q2 2021$6,785,000
-28.5%
1,735,372
-7.3%
0.00%
Q1 2021$9,490,000
+138.9%
1,871,809
+92.7%
0.00%
Q4 2020$3,973,000
-13.1%
971,280
+3.3%
0.00%
Q3 2020$4,572,000
-13.3%
940,704
-1.1%
0.00%
Q2 2020$5,271,000
+81.3%
951,395
+7.4%
0.00%
Q1 2020$2,907,000
-5.8%
886,163
+29.8%
0.00%
Q4 2019$3,086,000
+8.6%
682,7280.0%0.00%
Q3 2019$2,841,000
+25.3%
682,728
+14.1%
0.00%
Q2 2019$2,267,000
-9.9%
598,330
-0.3%
0.00%
Q1 2019$2,515,000
+81.5%
600,231
+7.8%
0.00%
Q4 2018$1,386,000
-61.6%
556,836
+12.6%
0.00%
Q3 2018$3,611,000
+99.5%
494,618
+1.1%
0.00%
Q2 2018$1,810,000
+5.6%
489,318
+9.9%
0.00%
Q1 2018$1,714,000
+5.2%
445,245
-1.6%
0.00%
Q4 2017$1,630,000
-14.9%
452,675
-6.7%
0.00%
Q3 2017$1,916,000
-24.4%
485,176
-2.3%
0.00%
Q2 2017$2,533,000
-31.9%
496,647
-7.9%
0.00%
Q1 2017$3,722,000
-25.7%
539,349
+0.7%
0.00%
Q4 2016$5,007,000
+3.3%
535,458
+8.1%
0.00%
Q3 2016$4,847,000
-23.1%
495,564
+11.1%
0.00%
Q2 2016$6,302,000
+8.8%
445,962
+7.7%
0.00%
Q1 2016$5,790,000
-20.5%
414,200
+16.0%
0.00%
Q4 2015$7,283,000
-96.1%
357,017
-93.1%
0.00%
-100.0%
Q3 2015$187,641,000
+5320.0%
5,172,560
+2192.1%
0.01%
Q2 2015$3,462,000
-10.4%
225,672
+16.7%
0.00%
Q1 2015$3,864,000
+21.5%
193,329
+27.8%
0.00%
Q4 2014$3,181,000
+20.1%
151,318
+6.3%
0.00%
Q3 2014$2,649,000
+90.2%
142,343
+136.0%
0.00%
Q2 2014$1,393,00060,3120.00%
Other shareholders
APPLIED GENETIC TECHNOL CORP shareholders Q2 2022
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,404,515$1,081,0002.01%
SABBY MANAGEMENT, LLC 811,973$625,0000.42%
Portolan Capital Management 1,605,599$1,236,0000.12%
Knoll Capital Management, LLC 100,000$77,0000.04%
Shay Capital LLC 50,000$39,0000.01%
COLONY GROUP LLC 330,287$254,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 155,375$120,0000.00%
MILLENNIUM MANAGEMENT LLC 1,499,124$1,154,0000.00%
Virtu Financial LLC 10,807$8,0000.00%
FIDUCIARY TRUST CO 40,000$31,0000.00%
View complete list of APPLIED GENETIC TECHNOL CORP shareholders